Overall rank by patents
#21,991
of 50,000 tracked assignees
USPTO PatentsView assignee record - 13 granted patents across 5 technology areas, recorded in grant years 2016–2020. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A01H (NEW PLANTS OR ; NON-TRANSGENIC; PROCESSES FOR OBTAINING THEM; PLANT REPRODUCTION BY TISSUE CULTURE TECHNIQUES).
The verdict
According to USPTO PatentsView, Vanguard ranks #21,991 of 50,000 tracked US assignees by granted-patent volume, with 13 patents across 5 technology areas.
USPTO PatentsView assignee plate
Corpus R21991 · US Corporation #21,991 · 13 grants
GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-DENSE · TYPE-USCORP · VEL-DROP · BOOK-FULL
Nearest grant-volume peer: Urogen Pharma Ltd. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
Qualcomm Incorporated · highest
85 score
Vanguard SEED · this assignee
31 score
3D Lighting Innovati… · lowest
7 score
What this shows Vanguard's Innovation Score is 30.8/100 (top 64% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Vanguard SEED, Inc. is a focused PatentsView assignee: 5 CPC subclasses with 100% of grants classified under A01H (NEW PLANTS OR ; NON-TRANSGENIC; PROCESSES FOR OBTAINING THEM; PLANT REPRODUCTION BY TISSUE CULTURE TECHNIQUES). Peak complete grant year is 2018 (5 grants) versus a trough of 1 in 2020. By volume, Vanguard sits between Urogen Pharma Ltd. and Verbio Vereinigte Bioenergie Ag.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
UroGen Pharma Ltd.
13 patents
Urugus S.A.
13 patents
VADOVATIONS, INC.
13 patents
VALOR FIRE SAFETY, LLC.
13 patents
VAULT PRESSURE CONTROL, LLC
13 patents
VCG Holdings Ltd.
13 patents
VENTRA GROUP CO.
13 patents
VERBIO VEREINIGTE BIOENERGIE AG
13 patents
VANGUARD SEED, INC.
13 patents
What this shows Vanguard holds 13 patents at rank #21,983, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #21,983 in granted patent volume.
Other assignees with the most granted patents in Vanguard's primary technology class.
Vanguard's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
31 Top 64% higher than 36% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2016 | 3 | 23.1% |
| 2017 | 2 | 15.4% |
| 2018 | 5 | 38.5% |
| 2019 | 2 | 15.4% |
| 2020 | 1 | 7.7% |
Top 5 of 5 technology areas
Overall rank by patents
#21,991
of 50,000 tracked assignees
30.8 out of 100
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.